Listed

Pliant Therapeutics, Inc.

PLRXNasdaqCIK 1746473HealthcareFiscal year ends Dec 31

Reports and events: 106 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Pliant Therapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2020-11-1016:18 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-20-052983
2020-08-1116:24 ET10-QQuarterly reportPeriod 2020-06-300001564590-20-039327
2020-08-1116:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-20-039317
2020-06-0206:08 ETS-1/ARegistration statement, amended0001193125-20-157787
2020-05-2606:14 ETS-1/ARegistration statement, amended0001193125-20-150643
2020-05-1121:49 ETS-1Registration statement0001193125-20-137876

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 15:38 ET. Listed shows no prices and gives no investment advice.